Partner – ICARS

Partner with us

ICARS believes that partnerships strengthen our efforts and increase our impact.

Driving change through partnerships

To advance our mission, we collaborate with national, regional, and international partners through a participatory, cross-disciplinary approach.

We prioritisalignment across public, private, and philanthropic sectors, ensuring our efforts complement rather than duplicate existing initiatives in the AMR space. Learn more about partnership opportunities below. 

For low- and middle-income countries

ICARS supports projects that are country-led and address local AMR priorities. 

Countries on the OECD DAC list may apply for funding and technical partnerships. Expressions of Interest are accepted from Ministries, or groups of Ministries, working together with national research institutions. 

For Implementation Partners

Sustainable, long-term change requires collaboration and integration with existing initiatives. 

ICARS works with national, regional and international organisations, civil society, and the private sector to expand the reach of AMR interventions and mobilize investment across sectors. 

For Funding Partners

Funding Partners provide the financial support and partnerships that make ICARS’ mission possible. 

Contributions from governments, foundations, and other institutions strengthen our capacity to deliver results and drive sustainable impact. These funds enable ICARS to work with LMICs to mitigate antimicrobial resistance effectively. 

For Mission Partners

Governments can join ICARS as Mission Partners, forming a global network of LMIC partners dedicated to sustainable AMR mitigation. 

Beyond project-level collaboration in countries, mission partnerships offer opportunities for advocacy and strategic engagement with ICARS for countries that share and support our vision and mission. 

Global leaders convene to advance sustainable solutions and financing for antimicrobial resistance mitigation
0 Total projects
in 2025
0 Countries & territories
in 2025
Partners
0 +
in 2025

What our partners say

“Fighting antibiotic resistance comes in small steps that should be strategic, orderly and well thought out. Well within the one health concept, our interventions start on the consumer’s table and ends in the environment. We are confident that with the solution we offer we can have an impact in the fight against antimicrobial resistance.”

Prof. Wejdene Mansour | Faculte de Medicine de Sousse
“The signing of this Memorandum of Understanding with the International Centre for Antimicrobial Resistance Solutions (ICARS), a prestigious Danish institution that stands out for its work in the search for scientific and collaborative solutions to address the global challenge of antimicrobial resistance (AMR), is very important…we will work with leading national educational institutions seeking to establish science-based measures to significantly reducing the use of antimicrobials in the salmon farming industry to establish better practices.”
Soledad Tapia Almonacid | National Director of Sernapesca, Chile
“The Tandem ABX has activated both strong scientific and health system competencies. It was great to see the strong commitment to rethink Antimicrobial Stewardship from ICARS’ partners in both Kenya and India”
Dr Nadia Boisen | Scientific Manager, Infectious Diseases, Novo Nordisk Foundation
“It wasn’t unusual to find a patient on three antibiotics when they needed one. That’s a cost first to the hospital, but also puts the patient at unnecessary risk as well. But, following the introduction of an antimicrobial stewardship (AMS) programme, behaviours began to change. We have seen a significant reduction, largely I think due to awareness that not every patient needs an antibiotic, and also, the use of laboratory information.”
Dr Duncan Chanda | Medical Director at the Institute for Medical Research and Training, Zambia